Connect
MJA
MJA

Editorials

The legitimacy of academic complementary medicine

Stephen P Myers, Charlie C Xue, Marc M Cohen, Kerryn L Phelps and George T Lewith

Med J Aust 2012; 197 (2): 69-70

A dog walking on its hind legs? Implications of the CareTrack study

Ian A Scott and Christopher B Del Mar

Med J Aust 2012; 197 (2): 67-68

Facilitating better end-of-life care

Geoffrey K Mitchell

Med J Aust 2012; 197 (2): 68-69

The spirit of the tent embassy: 40 years on

Peter O’Mara

Med J Aust 2012; 197 (1): 9-10 Free

Indigenous health: New Zealand experience

Mason H Durie

Med J Aust 2012; 197 (1): 10-11 Free

Gentamicin and ototoxicity: why this drug is still in use

John D Turnidge and John A Waterston

Med J Aust 2012; 196 (11): 665-666

Are trans fats a problem in Australia?

Gunveen Kaur, David Cameron-Smith and Andrew J Sinclair

Med J Aust 2012; 196 (11): 666-667

Is the end of chronic hepatitis C virus infection in sight?

Geoffrey W McCaughan

Med J Aust 2012; 196 (10): 614

Disciplinary notations on the Australian Register of Medical Practitioners

Ian R Freckelton

Med J Aust 2012; 196 (10): 612-613

Internet pornography and adolescent health

Rebecca J Guy, George C Patton and John M Kaldor

Med J Aust 2012; 196 (9): 546-547

Does football cause brain damage?

Andrew H Kaye and Paul McCrory

Med J Aust 2012; 196 (9): 547-549 Free

Evolving psychiatric diagnosis and the DSM: hasten slowly

Paul B Fitzgerald

Med J Aust 2012; 196 (9): 549-550

Survival from pancreatic cancer: it’s not just about the surgical mortality

Robert T A Padbury

Med J Aust 2012; 196 (8): 491-492

The need for regulation of office-based procedures

F A Hugh Bartholomeusz

Med J Aust 2012; 196 (8): 492-493

The urgency of saving lives through bowel cancer screening

Ian N Olver and Graeme P Young

Med J Aust 2012; 196 (8): 490-491

A call for national e-health clinical safety governance

Enrico W Coiera, Michael R Kidd and Mukesh C Haikerwal

Med J Aust 2012; 196 (7): 430-431

Avoiding adverse events with dabigatran by careful selection of eligible patients

Ross I Baker, Paul Harper and Claire McLintock

Med J Aust 2012; 196 (7): 431-432

New medicines — urgent need to assess outcomes in special groups

Jennifer H Martin and Michael D Coory

Med J Aust 2012; 196 (7): 433

Waiting in pain

Timothy J Semple and Malcolm N Hogg

Med J Aust 2012; 196 (6): 372-373 Free

Unrelieved pain: a major health care priority

Michael J Cousins

Med J Aust 2012; 196 (6): 373-374 Free

Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda

Wendy L Lipworth, Ian Kerridge and Richard O Day

Med J Aust 2012; 196 (6): 374-375

Infectious diseases in Australia — the next decade

Thomas Gottlieb, Bart J Currie and David F M Looke, on behalf of the Executive Council of the Australasian Society for Infectious Diseases

Med J Aust 2012; 196 (5): 292-293

The 20th century re-emergence of epidemic infectious diseases: lessons learned and future prospects

Duane J Gubler

Med J Aust 2012; 196 (5): 293-294

Educating Australia’s future doctors

Jennifer J Conn, David A Ellwood and James M Hillis

Med J Aust 2012; 196 (5): 295-296

Device regulation: what next?

Stephen E Graves and Guy J Maddern

Med J Aust 2012; 196 (4): 222-223